Last updated: July 13, 2026
Executive summary: Case 1:15-cv-03579 is a U.S. patent/ANDA-type enforcement action brought by Rite Aid Corporation against Endo Health Solutions Inc. The docket content needed to produce an accurate litigation narrative (claims asserted, listed patents, Paragraph IV status, settlement dates/terms, and final disposition) is not present in the provided input. Without those records, a complete and accurate litigation summary cannot be produced under the required standard.
What patents are at issue in Rite Aid Corp v. Endo Health Solutions Inc. (1:15-cv-03579)?
Featured snippet answer: Not determinable from the provided information.
Which Orange Book patents were asserted?
Featured snippet answer: Not determinable from the provided information.
Were claims directed to product formulation or method of use?
Featured snippet answer: Not determinable from the provided information.
Which jurisdictions and courts heard the dispute?
Featured snippet answer: Not determinable from the provided information.
What is the procedural posture of 1:15-cv-03579 and what happened next?
Featured snippet answer: Not determinable from the provided information.
Filing date, parties, and counsel
Featured snippet answer: Not determinable from the provided information.
Key motion milestones (TRO, preliminary injunction, dismissal, summary judgment)
Featured snippet answer: Not determinable from the provided information.
Claim construction and trial status
Featured snippet answer: Not determinable from the provided information.
What does the complaint allege in Rite Aid v. Endo Health Solutions?
Featured snippet answer: Not determinable from the provided information.
ANDA litigation theory (infringement, invalidity, non-infringement)
Featured snippet answer: Not determinable from the provided information.
Design-around arguments
Featured snippet answer: Not determinable from the provided information.
When does the case resolve and what is the final outcome?
Featured snippet answer: Not determinable from the provided information.
Settlement vs. judgment
Featured snippet answer: Not determinable from the provided information.
Who prevailed
Featured snippet answer: Not determinable from the provided information.
Ongoing injunction or license obligations
Featured snippet answer: Not determinable from the provided information.
How does this litigation affect generic entry risk for the Endo product?
Featured snippet answer: Not determinable from the provided information.
Paragraph IV outcomes and timing impacts
Featured snippet answer: Not determinable from the provided information.
Launch scheduling and “carve-outs” in settlements
Featured snippet answer: Not determinable from the provided information.
Practical barriers (manufacturing/IP constraints)
Featured snippet answer: Not determinable from the provided information.
What is the likely NDA/ANDA pathway link for 1:15-cv-03579?
Featured snippet answer: Not determinable from the provided information.
FDA status and regulatory posture
Featured snippet answer: Not determinable from the provided information.
Settlement-triggered approvals or stay lifting
Featured snippet answer: Not determinable from the provided information.
How does Endo’s patent estate compare with other ANDA defendants in similar Endo disputes?
Featured snippet answer: Not determinable from the provided information.
Patent count and claim breadth indicators
Featured snippet answer: Not determinable from the provided information.
Typical validity/infringement themes in Endo litigation
Featured snippet answer: Not determinable from the provided information.
Key case facts table (for docket-based decisioning)
| Field |
Value |
| Case |
Rite Aid Corporation v. Endo Health Solutions Inc. |
| Docket number |
1:15-cv-03579 |
| Court / division |
Not determinable from provided information |
| Asserted patents |
Not determinable from provided information |
| Drug / dosage form |
Not determinable from provided information |
| Type of action |
Not determinable from provided information |
| Core issues (infringement/validity/non-infringement) |
Not determinable from provided information |
| Procedural status |
Not determinable from provided information |
| Disposition (settlement/judgment) |
Not determinable from provided information |
| Entry impact |
Not determinable from provided information |
Key Takeaways
- No reliable litigation summary can be produced from the provided input because docket-level specifics (asserted patents, ANDA identifiers, claim allegations, motion outcomes, and disposition) are not present.
- A decision-grade analysis requires patent numbers and the disposition timeline; without those, downstream conclusions about exclusivity, launch timing, and damages exposure would be non-actionable.
FAQs
-
Which patents did Rite Aid assert in 1:15-cv-03579?
Not determinable from the provided information.
-
Was the case resolved by settlement or court judgment?
Not determinable from the provided information.
-
Did Endo receive an injunction or do the parties agree to a “launch-at-risk” posture?
Not determinable from the provided information.
-
How does this litigation affect FDA approval timelines for the relevant ANDA?
Not determinable from the provided information.
-
Are there companion cases involving the same Endo product and different plaintiffs/ANDA filers?
Not determinable from the provided information.
References
- Not available from the provided input.
